Lucid Diagnostics Inc

NASDAQ:LUCD   4:00:00 PM EDT
1.89
-0.08 (-4.06%)
7:02:50 PM EDT: $1.89 0.00 (0.00%)
Earnings Announcements

PAVmed Provides Third Quarter 2022 Financial Results

Published: 11/15/2022 22:17 GMT
Lucid Diagnostics Inc (LUCD) - Pavmed Inc - Qtrly Loss per Share $0.29.
Pavmed Inc - Qtrly Adjusted Loss per Share $0.15.
Revenue is expected to be $0.34 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0.75 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.